Journal profile · PERIPHERAL VASCULAR DISEASE
Cerebrovascular Diseases Extra
ISSN 1664-5456 · Karger Publishers · Switzerland
Cerebrovascular Diseases Extra: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.1 (journal website); fully open access; APC about USD 1,520; median 114 days to acceptance (56 articles, last 24 months); acceptance rate 46.8% (journal website); 29 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Cerebrovascular Diseases Extra is published by Karger Publishers and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Ischemic Stroke Management, Cerebrovascular and Carotid Artery Diseases and Stroke Rehabilitation and Recovery, together about 52.2% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Cerebrovascular Diseases Extra is an Open Access and online-only journal that focuses on informing the practice of stroke medicine and patient care in different world regions. This journal accepts original research papers, reviews, case series of particular interest, commentaries on clinical topics, case-based ethical issues, practice management tips, novel systems of care, and health policy discussions. Cerebrovascular Diseases Extra publishes content based on both independent submissions and submissions transferred from Cerebrovascular Diseases.
From the journal's Aims & Scope
Research area (LetPub): PERIPHERAL VASCULAR DISEASE
Editor-in-chief Craig S. AndersonPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Ischemic Stroke ManagementMedicine28.1%
- Cerebrovascular and Carotid Artery DiseasesMedicine14%
- Stroke Rehabilitation and RecoveryMedicine10.1%
- Intracerebral and Subarachnoid Hemorrhage ResearchMedicine9.5%
- Intracranial Aneurysms: Treatment and ComplicationsMedicine5.9%
- Atrial Fibrillation Management and OutcomesMedicine3.8%
- Moyamoya disease diagnosis and treatmentMedicine3.6%
- Venous Thromboembolism Diagnosis and ManagementMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Peripheral Vascular Disease | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPMCEmbasePublisher website
Other: Google Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.1Publisher website ·
- 5-year impact factor (publisher)
- 2.2Publisher website ·
- CiteScore 2026-06
- 3.7LetPub ·
- CiteScore (publisher)
- 3.7Publisher website ·
- SJR 2026-06
- 0.46LetPub ·
- SNIP 2026-06
- 0.88LetPub ·
- h-index
- 39OpenAlex ·
- i10-index
- 164OpenAlex ·
- 2-year mean citedness
- 3.19OpenAlex ·
- Self-citation rate
- 9.5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 29LetPub ·
Articles by year OpenAlex count · 326 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 21 | 21 | 4 |
| 2025 | 29 | 29 | 99 |
| 2024 | 29 | 29 | 149 |
| 2023 | 14 | 14 | 74 |
| 2022 | 18 | 18 | 216 |
| 2021 | 31 | 31 | 369 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
114 daysMedian, submission to acceptance · P25–P75 83 days – 170 days
- Acceptance to online
- median 13 days (56 articles)
- Submission to online
- median 127 days
- Sample
- 56 articles with submission and acceptance dates (57 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Acceptance rate (publisher)
- 46.8%Publisher website ·
- Submission to publication (journal-reported)
- about 17 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 1,330 / USD 1,520 / CHF 1,340 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 1,350 / EUR 1,150 / CHF 1,250 | — | — | |
| LetPub | EUR 1,330 / USD 1,520 / CHF 1,340 | Yes | — | |
| Publisher website | USD 1,670 / USD 1,280 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Keywords
- ≥ 3
- Reference style
- Vancouver
- Templates
- Word
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted14, with length limits
- brief reportailable below. For guidance purposes, a Brief Report is typically 3000 words in length and up to 3 Tables and Figures. Authors are askedmain text ≤ 3,000 words
- case seriesThis journal accepts original research papers, reviews, case series of particular interest, commentaries on clinical topics, case-based ethical issues, practice…Length not stated
- case-based ethical issuesThis journal accepts original research papers, reviews, case series of particular interest, commentaries on clinical topics, case-based ethical issues, practice…Length not stated
- commentaryThis journal accepts original research papers, reviews, case series of particular interest, commentaries on clinical topics, case-based ethical issues, practice…Length not stated
- editorialilable below. For guidance purposes, an Editorial is typically 1000 words in length and up to 3 Tables and Figures. Document Editoriamain text ≤ 1,000 words
- health policy discussionsThis journal accepts original research papers, reviews, case series of particular interest, commentaries on clinical topics, case-based ethical issues, practice…Length not stated
- letterailable below. For guidance purposes, a Letter is typically 1000 words in length and up to 3 Tables and Figures. Authors may wishmain text ≤ 1,000 words
- methods articleailable below. For guidance purposes, a Methods Article is typically 3000 words in length and up to 3 Tables and Figures. Authors are askedmain text ≤ 3,000 words
- novel systems of careThis journal accepts original research papers, reviews, case series of particular interest, commentaries on clinical topics, case-based ethical issues, practice…Length not stated
- original researchThis journal accepts original research papers, reviews, case series of particular interest, commentaries on clinical topics, case-based ethical issues, practice…Length not stated
- practice management tipsThis journal accepts original research papers, reviews, case series of particular interest, commentaries on clinical topics, case-based ethical issues, practice…Length not stated
- research articleailable below. For guidance purposes, a Research Article is typically 5000 words in length with 4 to 8 Tables and Figures. Authors are askedmain text ≤ 5,000 words
- reviewThis journal accepts original research papers, reviews, case series of particular interest, commentaries on clinical topics, case-based ethical issues, practice…Length not stated
- review articleailable below. For guidance purposes, a Review Article is typically 5000 words in length with 4 to 8 Tables and Figures. Document Review Amain text ≤ 5,000 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Self-archiving
- Authorship Author Contributions
In the Author Contribution statement, a short statement detailing the contributions of each person named as an author should be included. The CRediT taxonomy is a useful framework for preparing this section. Contributors to the submission who do not fulfil the ICMJE Criteria for Authorship should be credited, with their consent, in the Acknowledgement section.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Accepts submissions transferred from Cerebrovascular Diseases Model summary
Authors are required to disclose any relationship that could be perceived as a conflict of interest in the Conflict of Interest Statement. All forms of support and financial involvement which took place in the previous three years should be listed, regardless of their potential relevance to the paper. Nonfinancial relationships that may potentially influence the writing of the manuscript should al…
Source ↗Publisher website ·- Data availability Data Availability Statement
Authors are required to provide a Data Availability Statement that details whether data are publicly available and where the data supporting their study can be accessed. The journal’s data sharing policy strongly encourages authors to make all datasets on which the conclusions of the paper rely available to editors, reviewers and readers without unnecessary restriction wherever possible. In cases …
Source ↗Publisher website ·- License & copyright Licenses and Copyright
CC BY-NC 4.0 license Model summary
Articles published in Cerebrovascular Diseases Extra are licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, unless otherwise agreed with Karger Publishers. When sharing or reusing any article, attribution must be given to the original source, using the statement "The final, published version of this article is available at http://karger.com/?doi…
Source ↗Publisher website ·- Open access Open Access
Open Access Model summary
Open Access (All articles are published under Creative Commons licenses)
Source ↗Publisher website ·- Peer review Peer Review
Single-anonymous peer review Model summary
Peer Review Policy All Karger journals employ a rigorous peer-review process to confirm the validity and ensure scientific accuracy of published articles. Independent researchers with relevant expertise assess submitted manuscripts to help journal editors determine whether a manuscript should be published in their journal. All articles, except for Editorials and some Correspondence articles, are e…
Source ↗Publisher website ·- Self-archiving Archiving and Self-Archiving
All articles are archived in Portico. Articles may also be archived in PubMed Central if the journal is indexed there. Karger permits authors of Open Access articles to post the Version of Record (VOR) of their articles in Open Access repositories or on other websites. Preprints may be shared without restriction. Re-posted Open Access articles must follow the terms of the relevant Creative Commons…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Karger Publishers
- Country or region
- Switzerland
- Language
- English
- ISSN
- 1664-5456
- Latest issue on the website
- Volume 16, Issue 1 (December 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cerebrovascular Diseases Extra
What CAS zone is Cerebrovascular Diseases Extra in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cerebrovascular Diseases Extra is in Zone 4 of Medicine, and in Zone 4 of the minor category Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cerebrovascular Diseases Extra?
The journal's website gives an impact factor of 2.1; this is the journal's own figure, as LetPub lists none for it; CiteScore 3.7, h-index 39.
How long does peer review take at Cerebrovascular Diseases Extra?
Based on the dates recorded on 56 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 114 days (interquartile range 83–170 days); authors report an average review time of about 8 weeks; the journal's website gives an acceptance rate of 46.8%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Cerebrovascular Diseases Extra?
According to the journal's author guidelines: Keywords: ≥ 3; Reference style: Vancouver; Templates: Word; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Cerebrovascular Diseases Extra?
According to LetPub and DOAJ records, Cerebrovascular Diseases Extra is indexed in ESCI, Scopus and DOAJ. The journal's website also lists MEDLINE, PMC and Embase; that list has not been checked against each database.
Is Cerebrovascular Diseases Extra open access, and what is the APC?
Cerebrovascular Diseases Extra is a fully open-access journal. APC about USD 1,520.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .